MedTrace Logo

A Registry Study of Biomarkers in Heart Valve Disease

NCT06223906 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200000

Last updated 2024-01-26

No results posted yet for this study

Summary

Valvular Heart Disease, impacting 2.5% of the population, is predominantly observed in the elderly and is on the rise. The primary conditions within this category are Aortic Stenosis and Mitral Regurgitation. These conditions are linked to considerable morbidity and mortality, presenting a formidable challenge in optimizing treatment strategies. Pathophysiology of Valvular Heart Disease remains poorly known. The aim of the present study is to identify biomarkers involved in this disease using multi-omics approaches

Conditions

Sponsors & Collaborators

  • Beijing Institute of Heart, Lung and Blood Vessel Diseases

    lead OTHER

Principal Investigators

  • Jie Du, Dr · The Key Laboratory of Remodeling-Related Cardiovascular Disease, Ministry of Education, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart,Lung and Blood Vessel Diseases

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-01-01
Primary Completion
2030-01-01
Completion
2030-01-01

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06223906 on ClinicalTrials.gov